Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 14, 2014
NAD⁺ depletion by APO866 in combination with radiation in a prostate cancer model, results from an in vitro and in vivo studyShuraila F Zerp, Conchita Vens, Ben Floot, et al.
Chinese Clinical Oncology|April 6, 2015
New challenge of developing combined radio-drug therapyPhilippe Maingon, Anne-Sophie Govaerts, Sofia Rivera, et al.
Cancer Research|October 28, 2010
Targeted radiosensitization of cells expressing truncated DNA polymerase {beta}Sari Neijenhuis, Manon Verwijs-Janssen, Lenie J van den Broek, et al.
Nucleic Acids Research|June 28, 2002
The role of DNA polymerase beta in determining sensitivity to ionizing radiation in human tumor cellsConchita Vens, Els Dahmen-Mooren, Manon Verwijs-Janssen, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 9, 2008
Species-dependent transport and modulation properties of human and mouse multidrug resistance protein 2 (MRP2/Mrp2, ABCC2/Abcc2)Christian Zimmermann, Koen van de Wetering, Evita van de Steeg, et al.
DNA Repair|December 9, 2008
Mechanism of cell killing after ionizing radiation by a dominant negative DNA polymerase betaSari Neijenhuis, Manon Verwijs-Janssen, Ulla Kasten-Pisula, et al.
Oral Oncology|June 10, 2018
Comparative genomic analysis of oral versus laryngeal and pharyngeal cancerDavid M Vossen, Caroline V M Verhagen, Marcel Verheij, et al.
Oncotarget|September 1, 2018
DNA Repair Molecular Beacon assay: a platform for real-time functional analysis of cellular DNA repair capacityJianfeng Li, David Svilar, Steven McClellan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2016
Histopathology-derived modeling of prostate cancer tumor control probability: Implications for the dose to the tumor and the glandGhazaleh Ghobadi, Jeroen de Jong, Birgit G Hollmann, et al.
Cancers|September 9, 2022
Homologous Recombination Deficiency Scar: Mutations and Beyond-Implications for Precision OncologyAlexander M A van der Wiel, Lesley Schuitmaker, Ying Cong, et al.
Pageof 5